Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$344.87NASDAQ Previous Close - Last Trade as of 3:59PM ET 11/15/19

Today's Change0(0.00%)
Bid (Size)$330.12 (4)
Ask (Size)$344.87 (1)
Day Low / HighN/A - N/A
Volume912.2 K

Regeneron Pharmaceuticals Says Trial Shows Efficacy in Genetic Cholesterol Disorder Treatment

11:47AM ET 8/14/2019 MT Newswires
Regeneron Pharmaceuticals (REGN) said it achieved positive phase 3 trial results for evinacumab, a monoclonal antibody that specifically binds to angiopoietin-like protein 3 (ANGPTL3), in patients with homozygous familial hypercholesterolemia ((HoFH), a genetic disorder wherein patients have a high level of bad cholesterol or LDL cholesterol.

Price: 299.48, Change: -5.38, Percent Change: -1.76